LifeSciences
Senior Partner, Head of Life Sciences
AREAS OF INTEREST
The team focus on breakthrough therapies and platforms, deep science transforming human health, across all therapy areas and modalities.
Therapeutics
Tackling the world’s most urgent and complex diseases – from cancer and autoimmune conditions to neurodegeneration and vision loss.
Enabling platforms
Synthetic biology, antibody engineering, and other platform technologies unlocking new therapies and accelerating discovery.
Precision & personalised medicine
Tools for stratifying patients, identifying biomarkers, and targeting treatment – reshaping how we understand and treat disease.
Portfolio
From reprogramming immune cells to restoring sight, our companies are redefining what’s possible in human health.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting companies?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.